Vancouver WASHINGTON – January 6, 2016 --- “Essentially, if PRO 140 is FDA approved, the infected person could finally take a break and go on a vacation without having to remember their pills, and the exact times to take them each day. All they need is a reminder to inject a weekly dose of PRO 140 every seven days. We believe large numbers of HIVers are very much in need of PRO 140. They would be delighted to take a break from the stress of all those pills,” states Nader Pourhassan, President and CEO of CytoDyn Inc., clinical developer of PRO 140, an anti-body under development for HIV and GvHD.